• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM; COUNTER, DIFFERENTIAL CELL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM; COUNTER, DIFFERENTIAL CELL Back to Search Results
Model Number TN,DXH 800 HEMATOLOGY SYSTEM
Medical Device Problem Code Output Problem (3005)
Health Effect - Clinical Code Test Result (2695)
Date of Event 02/03/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The field service engineer (fse) was at the customer site on (b)(462 017 and observed that the dxh800 instrument was generating inconsistent plt counts.Bubbles were observed entering the system.The fse replaced the tubing between the diluent sensing board and the y-fitting to resolve the issue.The repairs were verified per established procedures.The failure mode is attributed to defective tubing in the diluent sensing board.Patient information was not provided by the customer.Beckman coulter is conducting a retrospective review of its global service records, to ensure that the records had been adequately evaluated for potential complaint information and any warranted follow-up action, including mdr reporting.  this mdr report is a result of that retrospective review.  an improvement for plt flagging was developed and released as a part of a software update to the dxh800 that is designated v3.2.1 on (b)(6) 2017; approximately 11.5% of the worldwide product installed base has been upgraded as of (b)(6) 2018.Due to an increase in the number of complaints received related to unflagged erroneously high plt patient results released from the lab, bec anticipates that a field action will be warranted.The anticipated field action will include a software patch for the improvement for the plt flagging component of v3.2.1, which will expedite installation of this improvement for the rest of the installed base.Bec internal identifier case- (b)(4).
 
Event or Problem Description
The customer reported that platelet (plt) results were not correlating on their unicel dxh 800 coulter cellular analysis system.There was no report of erroneous results reported out of the lab from the provided information.There was no report of change or effect to patient treatment in connection with the reported event.Patient data was not provided by the customer for this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM
Common Device Name
COUNTER, DIFFERENTIAL CELL
Manufacturer (Section D)
BECKMAN COULTER
250 s. kraemer blvd.
brea CA 92821
MDR Report Key7726748
Report Number1061932-2018-01005
Device Sequence Number683770
Product Code GKZ
UDI-Device Identifier15099590381646
UDI-Public(01)15099590381646(11)NO-DATA
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K140811
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional,user faci
Initial Reporter Occupation Other Health Care Professional
Remedial Action Repair,Recall,Notification,Modification/Adjustment
Type of Report Initial,Followup
Report Date (Section B) 08/28/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberTN,DXH 800 HEMATOLOGY SYSTEM
Device Catalogue Number629029
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer 02/03/2017
Supplement Date Received by Manufacturer07/30/2018
Initial Report FDA Received Date07/27/2018
Supplement Report FDA Received Date08/28/2018
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
2050012-0730/2018-011-C
Patient Sequence Number1
-
-